Synthetic glucocorticoid dexamethasone inhibits branching morphogenesis in the spiny mouse placenta

Biology of Reproduction

Volumn 88, Issue 1, 2013, Pages

  O'Connell, Bree A ^a   Moritz, Karen M ^b   Walker, David W ^a   Dickinson, Hayley ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Developmental origins of health and disease; Glucocorticoids; Glucorticoid receptor; Mice; Placentation; Rats; Rodents (guinea pigs; Stress; Voles)

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; DEXAMETHASONE; GREMLIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; WNT4 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; INNER EAR; MALE; MOUSE; NONHUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE;

ANIMALS; DEXAMETHASONE; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MURINAE; PLACENTA; PREGNANCY;

CAVIA; MURIDAE; MUS; MUS SAXICOLA; RATTUS; RODENTIA;

EID: 84877065060     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.112.100644     Document Type: Article

References (74)

1. Sugden MC, Langdown ML, Munns MJ, Holness MJ. Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growthretarded adult offspring. Eur J Endocrinol 2001; 145:529-539.
2. Wintour EM, Johnson K, Koukoulas I, Moritz K, Tersteeg M, Dodic M. Programming the cardiovascular system, kidney and the brain-a review. Placenta 2003; 24(suppl A):S65-S71.
3. Mayhew TM, Jenkins H, Todd B, Clifton VL. Maternal asthma and placental morphometry: effects of severity, treatment and fetal sex. Placenta 2008; 29:366-373.
4. Dodic M, Samuel C, Moritz K, Wintour EM, Morgan J, Grigg L, Wong J. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circulation Res 2001;89:623-629.
5. Kapoor A, Petropoulos S, Matthews SG. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res Rev 2008; 57:586-595.
6. Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 2008; 28:9055-9065.
7. Rodriguez JS, Zurcher NR, Keenan KE, Bartlett TQ, Nathanielsz PW, Nijland MJ. Prenatal betamethasone exposure has sex specific effects in reversal learning and attention in juvenile baboons. Am J Obstet Gynecol 2011; 204:545.e1-545.e10.
8. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001; 49:460-467.
9. Woods LL, Ingelfinger JR, Rasch R. Modest maternal protein restriction fails to program adult hypertension in female rats. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1131-R1136.
10. Bertram C, Trowern AR, Copin N, Jackson AA, Whorwood CB. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase. potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology 2001; 142:2841-2853.
11. Shoener JA, Baig R, Page KC. Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats. Am J Physiol Regul Integr Comp Physiol 2006; 290. R1366-R1373.
12. Dickinson H, Walker DW, Wintour EM, Moritz K. Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse. Am J Physiol Reg Integr Comp Physiol 2007; 292:R453-R461.
13. Wintour EM, Moritz KM, Johnson K, Ricardo S, Samuel CS, Dodic M. Reduced nephron number in adult sheep, hypertensive as a result of prenatal glucocorticoid treatment. J Physiol 2003; 549:929-935.
14. Dodic M, Abouantoun T, O'Connor A, Wintour EM, Moritz KM. Programming effects of short prenatal exposure to dexamethasone in sheep. Hypertension 2002; 40:729-734.
15. Ortiz LA, Quan A, Weinberg A, Baum M. Effect of prenatal dexamethasone on rat renal development. Kidney Int 2001; 59:1663-1669.
16. Benediktsson R, Calder AA, Edwards CR, Seckl JR. Placental 11 betahydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol 1997; 46:161-166.
17. Waddell BJ, Benediktsson R, Brown RW, Seckl JR. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action. Endocrinology 1998; 139:1517-1523.
18. Yang K. Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. Rev Reprod 1997; 2:129-132.
19. Burton PJ, Waddell BJ. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Biol Reprod 1999; 60:234-240.
20. Cuffe JS, Dickinson H, Simmons DG, Moritz KM. Sex specific changes in placental growth and MAPK following short term maternal dexamethasone exposure in the mouse. Placenta 2011; 32:981-989.
21. Audette MC, Challis JR, Jones RL, Sibley CP, Matthews SG. Antenatal dexamethasone treatment in midgestation reduces system A-mediated transport in the late-gestation murine placenta. Endocrinology 2011; 152:3561-3570.
22. O'Connell BA, Moritz KM, Roberts CT, Walker DW, Dickinson H. The placental response to excess maternal glucocorticoid exposure differs between the male and female conceptus in spiny mice. Biol Reprod 2011;85:1040-1047.
23. Hewitt DP, Mark PJ, Waddell BJ. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology 2006;147:5568-5574.
24. Ackerman WE, Bulmer JN, AM, Carter, Chaillet JR, Chamley L, CP, Chen, Chuong EB, SJ, Coleman, Collet GP, Croy BA, de Mestre AM, Dickinson H, et al. IFPA Meeting 2011 workshop report III: placental immunology; epigenetic and microRNA-dependent gene regulation. comparative placentation; trophoblast differentiation; stem cells. Placenta 2012; 33(suppl):S15-S22.
25. Iglesias DM, Hueber PA, Chu L, Campbell R, Patenaude AM, Dziarmaga AJ, Quinlan J, Mohamed O, Dufort D, Goodyer PR. Canonical WNT signaling during kidney development. Am J Physiol Renal Physiol 2007;293:F494-500.
26. Itoh N, Patel U, Cupp AS, Skinner MK. Developmental and hormonal regulation of transforming growth factor-beta1 (TGFbeta1), -2, and -. gene expression in isolated prostatic epithelial and stromal cells: epidermal growth factor and TGFbeta interactions. Endocrinology 1998; 139:1378-1388.
27. Lu MM, Yang H, Zhang L, Shu W, Blair DG, Morrisey EE. The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Dev Dyn 2001; 222:667-680.
28. Lamm ML, Podlasek CA, Barnett DH, Lee J, Clemens JQ, Hebner CM, Bushman W. Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev Biol 2001; 232:301-314.
29. Lang I, Schweizer A, Hiden U, Ghaffari-Tabrizi N, Hagendorfer G, Bilban M, Pabst MA, Korgun ET, Dohr G, Desoye G. Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential. Differentiation 2008; 76:1031-1043.
30. Fujiwara T, Dunn NR, Hogan BL. Bone morphogenetic protein 4 in the extraembryonic mesoderm is required for allantois development and the localization and survival of primordial germ cells in the mouse. Proc Natl Acad Sci U S A 2001; 98:13739-13744.
31. Sonderegger S, Husslein H, Leisser C, Knofler M. Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 2007; 28(suppl A):S97-S102.
32. Oshima M, Oshima H, Taketo MM. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996; 179:297-302.
33. Mak W, Shao X, Dunstan CR, Seibel MJ, Zhou H. Biphasic glucocorticoid-dependent regulation of Wnt expression and its inhibitors in mature osteoblastic cells. Calcif Tissue Int 2009; 85:538-545.
34. Baisden B, Sonne S, Joshi RM, Ganapathy V, Shekhawat PS. Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta. Placenta 2007; 28:1082-1090.
35. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10:1580-1594.
36. Bitgood MJ, McMahon AP. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995; 172:126-138.
37. Shi W, Zhao J, Anderson KD, Warburton D. Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis. Am J Physiol Lung Cell Mol Physiol 2001; 280. L1030-1039.
38. Basson CT, Kocher O, Basson MD, Asis A, Madri JA. Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-beta 1 correlates with reciprocal effects on cell migration. J Cell Physiol 1992; 153:118-128.
39. Madri JA, Bell L, Merwin JR. Modulation of vascular cell behavior by transforming growth factors beta. Mol Reprod Dev 1992; 32:121-126.
40. Madri JA, Pratt BM, Tucker AM. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 1988; 106:1375-1384.
41. Muller G, Behrens J, Nussbaumer U, Bohlen P, Birchmeier W. Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A 1987; 84:5600-5604.
42. Heimark RL, Twardzik DR, Schwartz SM. Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 1986; 233:1078-1080.
43. Winther H, Ahmed A, Dantzer V. Immunohistochemical localization ofvascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus. Placenta 1999; 20:35-43.
44. Dickinson H, Walker DW, Cullen-McEwen L, Wintour EM, Moritz K. The spiny mouse (Acomys cahirinus) completes nephrogenesis before birth. Am J Physiol Renal Physiol 2005; 289:F273-F279.
45. Brunjes PC. A stereological study of neocortical maturation in the precocial mouse, Acomys cahirinus. Brain Res 1985; 19:279-287.
46. Lamers WH, Mooren PG, De Graaf A, Charles R. Perinatal development of the liver in rat and spiny mouse. Its relation to altricial and precocial timing of birth. Eur J Biochem 1985; 146:475-480.
47. Oosterhuis WP, Mooren PG, Charles R, Lamers WH. Perinatal development of the lung in rat and spiny mouse: its relation to altricial and precocial timing of birth. Biol Neonate 1984; 45:236-243.
48. O'Connell BA, Moritz KM, Walker DW, Dickinson H. Sexually dimorphic placental development throughout gestation in the spiny mouse
49. Dickinson H, O'Connell BA, Quinn T, Cannata D, Moxham A, Walker DW. The spiny mousean ideal species to study perinatal biology. Pediatr Res 2010; 68:175.
50. Agulnik AI, Bishop CE, Lerner JL, Agulnik SI, Solovyev VV. Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven. Mamm Genome 1997; 8:134-138.
51. Rafiq K, Nakano D, Ihara G, Hitomi H, Fujisawa Y, Ohashi N, Kobori H, Nagai Y, Kiyomoto H, Kohno M, Nishiyama A. Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats. J Hypertens 2011; 29:290-298.
52. Ireland Z, Russell AP, Wallimann T, Walker DW, Snow R. Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse. BMC Dev Biol 2009; 9:39.
53. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav 2011; 59:279-289.
54. Seckl JR, Holmes MC. Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nat Clin Pract Endocrinol Metab 2007; 3:479-488.
55. O'Donnell K, O'Connor TG, Glover V. Prenatal stress and neurodevelopment of the child: focus on the HPA axis and role of the placenta. Dev Neurosci 2009; 31:285-292.
56. Monkley SJ, Delaney SJ, Pennisi DJ, Christiansen JH, Wainwright BJ. Targeted disruption of the Wnt2 gene results in placentation defects. Development 1996; 122:3343-3353.
57. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Ann Rev Cell Dev Biol 1998; 14:59-88.
58. Sugimura R, Li L. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res C Embryo Today 2010; 90:243-256.
59. Yao H, Ashihara E, Maekawa T. Targeting the Wnt/beta-catenin signaling pathway in human cancers. Expert Opin Ther Targets 2011; 15:873-887.
60. Boyer A, Lapointe E, Zheng X, Cowan RG, Li H, Quirk SM, DeMayo FJ, Richards JS, Boerboom D. WNT4 is required for normal ovarian follicle development and female fertility. FASEB J 2010; 24:3010-3025.
61. Tran HT, Sekkali B, Van Imschoot G, Janssens S, Vleminckx K. Wnt. beta-catenin signaling is involved in the induction and maintenance of primitive hematopoiesis in the vertebrate embryo. Proc Natl Acad Sci U S A 2010; 107:16160-16165.
62. Elizalde C, Campa VM, Caro M, Schlangen K, Aransay AM, Vivanco M, Kypta RM. Distinct roles for Wnt-4 and Wnt-11 during retinoic acidinduced neuronal differentiation. Stem Cells 2011; 29:141-153.
63. Kiba A, Sagara H, Hara T, Shibuya M. VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. Biochem Biophys Res Comm 2003; 301:371-377.
64. Grbesa D, Durst-Zivkovic B. The surface of the syncytiotrophoblast in the human placenta at term in relation to the sex of the neonate. [Article in Croatian.] Jugosl Ginekol Perinatol 1989; 29:169-171.
65. Eriksson JG, Kajantie E, Osmond C, Thornburg K, Barker DJ. Boys live dangerously in the womb. Am J Hum Biol 2010; 22:330-335.
66. Clifton VL. Review: Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta 2010; 31(suppl):S33-S39.
67. Coan PM, Ferguson-Smith AC, Burton GJ. Ultrastructural changes in the interhaemal membrane and junctional zone of the murine chorioallantoic placenta across gestation. J Anat 2005; 207:783-796.
68. Wang J, Kuliszewski M, Yee W, Sedlackova L, Xu J, Tseu I, Post M. Cloning and expression of glucocorticoid-induced genes in fetal rat lung fibroblasts. Transforming growth factor-beta 3. J Biol Chem 1995; 270:2722-2728.
69. Oursler MJ, Riggs BL, Spelsberg TC. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology 1993; 133:2187-2196.
70. Dickinson H, O'Connell BA, Quinn T, Bernard L, O'Tierney P, Louey S, Thornburg KL, Moritz KM, Walker DW. Excess maternal glucocorticoids during mid-gestation: sexually dimorphic consequences for many organ systems. Pediatr Res 2010; 68:175.
71. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187:1579-1586.
72. Murphy VE, Gibson P, Talbot PI, Clifton VL. Severe asthma exacerbations during pregnancy. Obstet Gynecol 2005; 106:1046-1054.
73. Vonnahme KA, Wilson ME, Ford SP. Relationship between placental vascular endothelial growth factor expression and placental/endometrial vascularity in the pig. Biol Reprod 2001; 64:1821-1825.
74. Thornburg KL, O'Tierney PF, Louey S. Review: The placenta is a programming agent for cardiovascular disease. Placenta 2010; 31(suppl). S54-S59.